Sign in Subscribe

GE HealthCare to Buy Sofie Biosciences for $945 Million, Adding U.S. PET Tracer Network

Sofie joins GE HealthCare's diagnostics unit in a $945 million cash deal that adds U.S. PET manufacturing and FAPI-74 rights.

GE HealthCare to Buy Sofie Biosciences for $945 Million, Adding U.S. PET Tracer Network
"SOFIE Biosciences has 15 CMO sites across the U.S., manufacturing PET radiopharmaceutical products." Credit: GE HealthCare/BUSINESS WIRE
Already have an account? Sign in.